title: [ACE inhibitors--a prospective new group of drugs for the treatment of kidney diseases].
abstract: ACE inhibitors which till recently were used only in the treatment of cardiovascular diseases are becoming a perspective group of drugs also in the treatment of chronic nephropathies. It was revealed that they are effective in particular in the treatment of proteinuria of different etiology and have also a marked renoprotective effect and are therefore recommended to slow down the progression of renal failure. They reduce intraglomerular hypertension, increase glomerular filtration and the renal blood flow, and it is assumed that they can retard the progression of chronic glomerulonephritis and diabetic nephropathy. It may be excepted that their therapeutic application will in the near future be extended also to clinical nephrology.
authors.affiliation: Detská klinika LF UPJS, Kosice.
authors.forename: L
authors.initials: L
authors.lastname: Podracká
authors.forename: M
authors.initials: M
authors.lastname: Sasinka
authors.forename: A
authors.initials: A
authors.lastname: Böör
mesh_terms: D000806:Angiotensin-Converting Enzyme Inhibitors / Q000009:adverse effects / Q000493:pharmacokinetics / Q000627:therapeutic use*; D006801:Humans; D007674:Kidney Diseases / Q000188:drug therapy*
chemical_list: D000806:Angiotensin-Converting Enzyme Inhibitors
vernacular_title: Inhibitory ACE--nová perspektivna skupina liekov v terapii oblickových chorb.